Loading…
Reported covered position: 89-92, Asst. Sec., HHS; 93,COS, Rep. Molina
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
(1) Issues related to Public Law 111-148 The Patient Protection and Affordable Care Act; (2) Issues related to Public Law 111-152 Health Care and Education Reconciliation Act of 2010; (3) Issues raised by H.R. 2077 - MLR Repeal Act of 2011(repeal ACA's Medical Loss Ratio requirements); and (4) Issues related to implementation of the Affordable Care Act, including Exchanges, Essential Health Benefits, affordability, health information technology, transparency, employer regulations, and taxes and fees.
To provide for expedited consideration by the Supreme Court of certain actions challenging the constitutionality of certain provisions of the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AETNA INC via AETNA INC.
2012 · third_quarter · Q3
(1) Issues related to Public Law 112-25 - The Budget Control Act of 2011 and; (2) General issues related to reducing the federal deficit, including efforts to bring down health care costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Treasury, Dept of
AETNA INC via AETNA INC.
2012 · second_quarter · Q2
Source: Senate LDA
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
To provide for expedited consideration by the Supreme Court of certain actions challenging the constitutionality of certain provisions of the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
To provide for expedited consideration by the Supreme Court of certain actions challenging the constitutionality of certain provisions of the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
To provide for expedited consideration by the Supreme Court of certain actions challenging the constitutionality of certain provisions of the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
To provide for expedited consideration by the Supreme Court of certain actions challenging the constitutionality of certain provisions of the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid).
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid)
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); s. 848 (Diasclosure of Medicare Provider data); HR 1031.
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Access to Professional Health Insurance Advisors Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
National Strategic and Critical Minerals Policy Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
National Strategic and Critical Minerals Policy Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
National Strategic and Critical Minerals Policy Act of 2011
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Client: AETNA INC · Firm: AETNA INC.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Medicare Prescription Drug Savings and Choice Act of 2011
Client: AETNA INC · Firm: AETNA INC.
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number);
Medicare Prescription Drug Savings and Choice Act of 2011
Client: AETNA INC · Firm: AETNA INC.
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number);
Medicare Prescription Drug Savings and Choice Act of 2011
Client: AETNA INC · Firm: AETNA INC.
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid)
Medicare Prescription Drug Savings and Choice Act of 2011
Client: AETNA INC · Firm: AETNA INC.
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid).
Medicare Prescription Drug Savings and Choice Act of 2011
Client: AETNA INC · Firm: AETNA INC.
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); s. 848 (Diasclosure of Medicare Provider data); HR 1031.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) H 975 (mammography mandate); HR 1339 (Mandate to cover deformities)
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) H 975 (mammography mandate); HR 1339 (Mandate to cover deformities)
(1) H.CON.RES. 34 Establishing the budget for the United States Government for fiscal year 2012 and setting forth appropriate budgetary levels for fiscal years 2013 through 2021; (2) Issues related to Public Law 112-25 - The Budget Control Act of 2011; and (3) general issues related to reducing the federal deficit, including efforts to bring down health costs.
(1) Issues related to Public Law 111-148 The Patient Protection and Affordable Care Act; (2) Issues related to Public Law 111-152 Health Care and Education Reconciliation Act of 2010; (3) Issues raised by H.R. 2077 - MLR Repeal Act of 2011(repeal ACA's Medical Loss Ratio requirements); and (4) Issues related to implementation of the Affordable Care Act, including Exchanges, Essential Health Benefits, affordability, health information technology, transparency, employer regulations, and taxes and fees.
(1) Issues related to Public Law 111-148 The Patient Protection and Affordable Care Act; (2) Issues related to Public Law 111-152 Health Care and Education Reconciliation Act of 2010; and (3) issues related to the Affordable Care Act's implementation, including Medical Loss Ratio, taxes, Exchanges, Essential Health Benefits, affordability, health information technology, transparency and employer regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Treasury, Dept of
AETNA INC via AETNA INC.
2012 · first_quarter · Q1
(1) Public Law 111-148 The Patient Protection and Affordable Care Act; and (2) Public Law 111-152 Health Care and Education Reconciliation Act of 2010. Issues related to the health reform laws implementation, including medical loss ratio (MLR), taxes, exchanges, essential health benefits, affordability, health information technology, transparency and employer regulations.
(1) Public Law 111-148 The Patient Protection and Affordable Care Act; and (2) Public Law 111-152 Health Care and Education Reconciliation Act of 2010. Issues related to the health reform laws implementation, including medical loss ratio (MLR), taxes, exchanges, essential health benefits, affordability, health information technology, transparency and employer regulations.
(1) H.CON.RES. 34 Establishing the budget for the United States Government for fiscal year 2012 and setting forth appropriate budgetary levels for fiscal years 2013 through 2021; (2) Public Law 112-25 - The Budget Control Act of 2011. General issues related to reducing the federal deficit, including efforts to bring down health costs, by improving and expanding care delivery models that reward quality and patient outcomes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Personnel Management (OPM), SENATE, Treasury, Dept of
AETNA INC via AETNA INC.
2011 · fourth_quarter · Q4
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number);
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AETNA INC via AETNA INC.
2011 · second_quarter · 2A
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid).
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AETNA INC via AETNA INC.
2011 · third_quarter · Q3
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); s. 848 (Diasclosure of Medicare Provider data); HR 1031.
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
AETNA INC via AETNA INC.
2011 · second_quarter · Q2
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number); S. 848 (Disclosure of Medicare provider data); HR 1031 (Medicaid)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
AETNA INC via AETNA INC.
2011 · first_quarter · Q1
S. 31 and S. 44 (Allow HHS to directly negotiate drug prices); S. 560 and HR 999 (Establishes Medicare-run Part D PDP nationwide); Proposals to extend the "Doc Fix" beyond 12/31/ 2011. Medicaid Maintenance of Effort repeal (No Bill Number); Medicare Advantage Open Enrollment period (No Bill Number);
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to covvect excessive insurance rates);
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
AETNA INC via AETNA INC.
2010 · first_quarter · 1A
HR 1583 (McCarran-Ferguson). S 819 (Autism). HR 1253 (disclosure rules) HR 1691/S 688 (prohibit plan rescissions and establish minimum hospital stays for cancer patients) HR 1558/S623 ; also HR 1619, S. 643, HR 1092 (prohibit pre-existing condition exclusions). S. 442/ HR 1085 (prohibit aggregate lifetime limit) S. 697 /HR 1721 (Long Term Care) HR 975 (Mammography mandate) HR 1339 (Mandate to cover deformities)
HR 1086 (Medical Malpractice liability reform)
HR 1 ARRA (increase in FMAP and moratorium on Medicaid Regulations). HR 2 SCHIP, HR 904/S 547 (Medicaid drug rebates). HR 684/S 330 (establish Government PDPs). S 266 (government run negotiation of drug prices in Medicare.) S 75 (to promote generic drugs in Medicare). S 677 (means-test Part B premiums). S 1832 (to regulate Part D plan prices). S 960 (Medicare Buy-In for age 55-64). HR 3961 ("Doc Fix"). S. 2128 (MM Fraud & Abuse) S 1776 (SGR).
AETNA INC via AETNA INC.
2010 · fourth_quarter · Q4
HR 1 American Recovery and Reinvestment Act (increase FMAP, and moratorium on Medicaid regulations) HR 2, SCHIP. HR 904/S 547 (Medicaid drug rebates) HR 684/S. 330 (to establish government-run PDP) S. 266 (government run negotiation of drug prices in Medicare) S. 75 (to promote generic drugs in Medicare). S. 677 (to means-test Part B Premiums). S. 1832 (to regulate Part D plan prices). S.960 (Medicare Buy in); HR 3961 ("Doc Fix"); S. 2128 (MM Fraud & Abuse); S. 1776 (SGR). HR 3590/HR 48
HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). A. 1796, S. 1679 (Health Care Reform); HR 676/S. 703 (Single payer): PL 111-148; PL 111-152.
AETNA INC via AETNA INC.
2010 · third_quarter · Q3
HR 1 American Recovery and Reinvestment Act (increase FMAP, and moratorium on Medicaid regulations) HR 2, SCHIP. HR 904/S 547 (Medicaid drug rebates) HR 684/S. 330 (to establish government-run PDP) S. 266 (government run negotiation of drug prices in Medicare) S. 75 (to promote generic drugs in Medicare). S. 677 (to means-test Part B Premiums). S. 1832 (to regulate Part D plan prices). S.960 (Medicare Buy in); HR 3961 ("Doc Fix"); S. 2128 (MM Fraud & Abuse); S. 1776 (SGR). HR 3590/HR 48
HR 1086 (Medical Malpractice Liability Reform)
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) H 975 (mammography mandate); HR 1339 (Mandate to cover deformities)
AETNA INC via AETNA INC.
2010 · second_quarter · Q2
HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). A. 1796, S. 1679 (Health Care Reform); HR 676/S. 703 (Single payer): PL 111-148; PL 111-152.
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) H 975 (mammography mandate); HR 1339 (Mandate to cover deformities)
AETNA INC via AETNA INC.
2010 · first_quarter · Q1
HR 1086 (Medical Malpractice liability reform)
HR 1 ARRA (increase in FMAP and moratorium on Medicaid Regulations). HR 2 SCHIP, HR 904/S 547 (Medicaid drug rebates). HR 684/S 330 (establish Government PDPs). S 266 (government run negotiation of drug prices in Medicare.) S 75 (to promote generic drugs in Medicare). S 677 (means-test Part B premiums). S 1832 (to regulate Part D plan prices). S 960 (Medicare Buy-In for age 55-64). HR 3961 ("Doc Fix"). S. 2128 (MM Fraud & Abuse) S 1776 (SGR).
HR 1583 (McCarran-Ferguson). S 819 (Autism). HR 1253 (disclosure rules) HR 1691/S 688 (prohibit plan rescissions and establish minimum hospital stays for cancer patients) HR 1558/S623 ; also HR 1619, S. 643, HR 1092 (prohibit pre-existing condition exclusions). S. 442/ HR 1085 (prohibit aggregate lifetime limit) S. 697 /HR 1721 (Long Term Care) HR 975 (Mammography mandate) HR 1339 (Mandate to fcover deformities)
AETNA INC via AETNA INC.
2009 · fourth_quarter · Q4
S 1796, S 1679, HR 3962, HR 3590 (Health Care Reform). HR 1204 (Antitrust exemption for pharmacists) HR 1493 (Antitrust exemption for physicians) HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT). HR 1427/S 726/ HR 1548 (FDA PAthway to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (Generic/brand settlements). S. 93 (establish FEHBP for small employers) S 391/HR 1321 (National health insurance) HR 676/S. 703 (single payer health plan)
HR 1583 (McCarran-Ferguson). S 819 (Autism). HR 1253 (disclosure rules) HR 1691/S 688 (prohibit plan rescissions and establish minimum hospital stays for cancer patients) HR 1558/S623 ; also HR 1619, S. 643, HR 1092 (prohibit pre-existing condition exclusions). S. 442/ HR 1085 (prohibit aggregate lifetime limit) S. 697 /HR 1721 (Long Term Care) HR 975 (Mammography mandate) HR 1339 (Mandate to fcover deformities)
AETNA INC via AETNA INC.
2009 · third_quarter · Q3
HR 1086 (Medical Malpractice Liability Reform)
HR 1 American Recovery and Reinvestment Act (increase FMAP, and moratorium on Medicaid regulations) HR 2, SCHIP. HR 904/S 547 (Medicaid drug rebates) HR 684/S. 330 (to establish government-run PDP) S. 266 (government run negotiation of drug prices in Medicare) S. 75 (to promote generic drugs in Medicare). S. 677 (to means-test Part B Premiums). S. 1832 (to regulate Part D plan prices). S. 960 ("Buy-In" to Medicare, age 55-64)
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) HR 975 (Mammography mandate). HR 1339 (Mandate to cover deformities)
AETNA INC via AETNA INC.
2009 · second_quarter · Q2
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) HR 1339 (Mandate for Developmental deformities); HR 995 (mandate for mammography)
HR 1 American Recovery and Reinvestment Act (increase FMAP, and moratorium on Medicaid regulations) HR 2, SCHIP. HR 904/S 547 (Medicaid drug rebates) HR 684/S. 330 (to establish government-run PDP) S. 266 (government run negotiation of drug prices in Medicare) S. 75 (to promote generic drugs in Medicare). S. 677 (to means-test Part B Premiums). S. 1832 (to regulate Part D plan prices). S. 960 Medicare "Buy-In"
AETNA INC via AETNA INC.
2009 · first_quarter · Q1
HR 1086 (Medical Malpractice Liability Reform)
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care)
HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all")
AETNA INC via AETNA INC.
2008 · fourth_quarter · Q4
HR 3162, Children's Health & Medicare Protection Act of 2007 (Medicare Payment/Reimbursement Reform); S.1218/HR 2034, Medicare for All Act (Medicare "buy-in"); S. 130/HR 1990, Medicare Cost Contract Extension & Retirement Act of 2007 (private sector role in Medicare); S 3/HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 (Government Negotiation of Medicare Drug Prices); S 1102, Part D Equity for Low Income Seniors Act of 2007 (Special benefits for low income seniors); HR 1663, Medicare Mental Health Modernization Act of 2007 (Medicare Mental Health Parity); HR 976, Children's Health Insurance Program Reauthorization Act of 2007 (SHIP Extension and Expansion); HR 2184, Enhanced Health Care Value for All Act of 2007 (Comparative Effectiveness Research Institute; HR 971, Community Pharmacy Fairness Act of 2007 (Medicare Pharmacist Antitrust Exemption), HR 4327, Medicare Chronic Care Practice Network (Establish a Medicare Chronic Care Practice Research Network to develop and evaluate evidence based chronic care management for Medicare beneficiaries); HR 1193, Kidney Care Quality and Education Act of 2007 (Modernize and improve the Medicare ESRD program); HR 6331, Electronic Prescription in Medicare; HR 6331, Medicare Improvements Act of 2008 (dealing with physician reimbursements and Medicare Advantage funding cuts); H. Res. 1368, Medicare "trigger" to warn against funding problem.
AETNA INC via AETNA INC.
2008 · third_quarter · Q3
HR 493/S 358, Genetic Information Nondiscrimination Act of 2007; H 2761, Terrorism Risk Insurance Revision and Extension Act of 2007 (Include life insurance provision); S1588, Children's Access to Reconstructive Evaluation and Surgery Act (Mandated coverage for congenital disease/deformity); H836, Cyber-Security Enhancement and Consumer Data Protection Act of 2007 (Privacy and data security provisions); HR 948, Social Security Number Protection Act of 2007; S 495, Personal Data Privacy and Security Act of 2007; S 1408, Health Information Technology Act of 2007 (Provision on using technology for quality); HR 3425, Cancer Screening Coverage Act of 2007 (Mandated cancer screening); HR 3341, Quality Health Care Coalition Act of 2007 (Provision exempting physicians from antitrust laws); S 459/HR 758, Breast Cancer Patient Protection Act of 2007 (Minimum hospital stay for breast cancer); S 40, National Insurance Act of 2007 (Optional federal charter for insurance); S 400/HR 2851, Michelle's Law (Mandatory coverage for students when on medical leave); HR 4460/S 2477, Health Care Choice Act of 2007 (Cross-state selling of insurance); HR 4986, National Defense Authorization Act for Fiscal Year 2008 (Provision that extends Family Medical Leave Act to service members); S 1881/HR 3195, ADA Restoration Act of 2007; HR 6142, (ERISA and disability benefit damages); HR 5840, Insurance Information Act of 2008; S 3406, ADA Amendments Act.
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S.137 (mechanism for HHS/states to covvect excessive insurance rates); HR 605 (repeal FSA/HSA OTC restrictions); S. 312 (Repeals OTC restrictions); HR 2010/S.1089 (Expand use of HSAs); HR 1206; (excluse commissions from MLR); HR 1050 (creates AHPs); HR 371 (Cross-State selling)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
HR 1050 (allows for Association Health Plans free from state mandated benefits); HR 346 (allows for national insurance marketplace via cross-state purchsing of coverage); HR 416/S. 137 (mechanism for HHS/states to correct excessive insurance rates); HR 605 (repeal FSA/HSA OTC restriction); S. 312 (Repeals OTC restriction); HR 2010/S. 1089 (expand use of HSAs); HR 1206 (exclude Commissions from MLR calculation). HR 1050 (Creates AHPs-Association Health Plans); HR 371 (Cross-state selling).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
S 1796, S 1679, HR 3962, HR 3590 (Health Care Reform). HR 1204 (Antitrust exemption for pharmacists) HR 1493 (Antitrust exemption for physicians) HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT). HR 1427/S 726/ HR 1548 (FDA PAthway to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (Generic/brand settlements). S. 93 (establish FEHBP for small employers) S. 391/H.R. 1321 (National health) H.R. 676/S. 703 (single payer); PL 111-148; PL 111-152.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HR 1086 (Medical Malpractice Liability Reform)
HR 1583 (Mccarran-Ferguson). S. 819 (mandate autism coverage). HR 1253 (new plan disclosure rules). HR 1691/S. 688 (prohibit plan rescissions and establish minimum length of hospital stays for cancer patients) HR 1558/S. 623 (prohibit pre-existing condition exclusions; also HR 1619, S. 643, HR 1092) S. 442/ HR 1085 (to prohibit aggregate lifetime dollar limit) S> 697/HR 1721 (Long Term Care) H 975 (mammography mandate); HR 1339 (Mandate to cover deformities)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). A. 1796, S. 1679 (Health Care Reform); HR 676/S. 703 (Single payer): PL 111-148; PL 111-152.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
HR 1086 (Medical Malpractice Liability Reform)
HR 1 American Recovery and Reinvestment Act (increase FMAP, and moratorium on Medicaid regulations) HR 2, SCHIP. HR 904/S 547 (Medicaid drug rebates) HR 684/S. 330 (to establish government-run PDP) S. 266 (government run negotiation of drug prices in Medicare) S. 75 (to promote generic drugs in Medicare). S. 677 (to means-test Part B Premiums). S. 1832 (to regulate Part D plan prices). S.960 (Medicare Buy in); HR 3961 ("Doc Fix"); S. 2128 (MM Fraud & Abuse); S. 1776 (SGR).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
S 1796, S 1679, HR 3962, HR 3590 (Health Care Reform). HR 1204 (Antitrust exemption for pharmacists) HR 1493 (Antitrust exemption for physicians) HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT). HR 1427/S 726/ HR 1548 (FDA PAthway to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (Generic/brand settlements). S. 93 (establish FEHBP for small employers) S 391/HR 1321 (National health) HR 676/S. 703 (single payer); PL 111-148; PL 111-152.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HR 1086 (Medical Malpractice liability reform)
HR 1 ARRA (increase in FMAP and moratorium on Medicaid Regulations). HR 2 SCHIP, HR 904/S 547 (Medicaid drug rebates). HR 684/S 330 (establish Government PDPs). S 266 (government run negotiation of drug prices in Medicare.) S 75 (to promote generic drugs in Medicare). S 677 (means-test Part B premiums). S 1832 (to regulate Part D plan prices). S 960 (Medicare Buy-In for age 55-64). HR 3961 ("Doc Fix"). S. 2128 (MM Fraud & Abuse) S 1776 (SGR).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all"). S. 1099/HR2520 (Federal-State "One Stop Shopping" for health care). S. 979/HR 2360 (SHOP Act-Small business coverage). HR 859 (CHOICE Act-small business coverage). HR 2502 (Comparative Effectiveness Research). HR 3200 (House Tri-Committee health care reform bill).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HR 1086 (Medical Malpractice Liability Reform)
HR 1204 (Antitrust exception for Pharmacists). HR 1493 (Antitrust exemption for physicians). HR 1 (COBRA coverage subsidy; comparative effectiveness, wellness, HIT finding and privacy). HR 1427/S. 726/ HR 1548 (FDA pathwqy to approve generic Biopharmaceutical medicines). S. 369/HR 1706 (generic/brand "settlements"). S. 93 (establish FEHBP for small employers. S. 391/ HR 1321 (National health insurance). HR 676/S. 703 (single-payer health plan) HR 193 (Medicare "for all")HR 2502; HR 2399 S. 1099/HR 2520
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 1 American Recovery and Reinvestment Act (increase FMAP, and moratorium on Medicaid regulations) HR 2, SCHIP. HR 904/S 547 (Medicaid drug rebates) HR 684/S. 330 (to establish government-run PDP) S. 266 (government run negotiation of drug prices in Medicare) S. 75 (to promote generic drugs in Medicare). S. 677 (to means-test Part B Premiums). S. 1832 (to regulate Part D plan prices).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
S 1893, Children's Health Insurance Program Reauthorization Act of 2007 (Expansion/extension of SCHIP ); S558/HR 1424, Mental Health Parity Act of 2007 (Secure equal treatment for mental health benefits); HR 1038/S 623, Access to Life-Saving Medicine Act (Biogenerics-approving generic Bio pharmaceuticals); S 316, Preserve Access to Affordable Generics Act (Regulate Generic/Brand patent settlements); S 1501/S 1695, Affordable Biologics for Consumers Act (Generic Bio-pharmaceuticals); S 334, Healthy Americans Act (Universal health coverage replaces employer coverage); S 1899, Universal Health Coverage Act of 2007 (Mandatory health insurance coverage); S 242/HR 380, Pharmaceutical Market Access and Drug Safety Act of 2007 (Drug importation-Canada, et al.); HR 1076/S616, HIPAA Recreational Injury Technical/Correction Act (Mandatory coverage for recretional activity); HR 676, United States National Health Insurance Act (National health insurance); HR 1368, Personalized Health Information Act of 2007 (Financial incentives for personal health records); S 1490, Federal Employees Electronic Personal Health Records Act of 2007 (health information technology); S 1544, Medicare Quality Enhancement Act of 2007 (CMS data release); S 1693, Wired for Health Care Quality Act (Health information technology); HR 1368, Personalized Health Information Act of 2007; HR 5422, TRUST in Health Information Act of 2008; S 1693, Wired for Health Care Quality Act; S 1814, Health Information Privacy and Security Act; HR 6357, ProTecht Act of 2008; HR 6898, Health Information Technology Act of 2008; HR 6582, Small Business Choice Act of 2008; S 2795, SHOP Act; HR 6210, SHOP Act; S 2818, Small Busienss Health Plans Act of 2008.
HR 914, Tax equity and Affordability Act of 2007; HR 2639, Promoting Health for Future Generations Act of 2007; HS 3234, HSA Improvement and Expansion Act of 2007, S 46, Affordability in the Individual Market Act; S 397, Tax Equity and Affordability Act of 2007; HR 5719, Taxpayer Assistance & Simplification Act (HSAs); HR 3997, Heroes Earnings Assistance and Relief Tax Act of 2007 (FSA); HR 2638, Consolidated Security, Disaster Assistance & Continuing Approp. Act; HR 6049, Energy Improvement & Extension Act (tax extenders, DMT); HR 7005, Alternative Minimum Tax Relief Act of 2008; HR 7060, Renewable Energy & Job Creation Tax Act of 2008 (Tax extenders); HR 6288, Retiree Health Account of 2008.
S1481/HR 2497, Fair and Reliable Medical Justice Act (Medical malpractice reform/health courts); S618, Insurance Competition Act of 2007 (Repeal McCarran-Ferguson); HR 3341, Quality Health Care Coalition Act (Physician antitrust exemption)
HR 3361, Pension Protection Technical Corrections Act of 2008; HR 6143, Pension Protection Act ERISA Amendments of 2008
HR 493/S 358, Genetic Information Nondiscrimination Act of 2007; H 2761, Terrorism Risk Insurance Revision and Extension Act of 2007 (Include life insurance provision); S1588, Children's Access to Reconstructive Evaluation and Surgery Act (Mandated coverage for congenital disease/deformity); H836, Cyber-Security Enhancement and Consumer Data Protection Act of 2007 (Privacy and data security provisions); HR 948, Social Security Number Protection Act of 2007; S 495, Personal Data Privacy and Security Act of 2007; S 1408, Health Information Technology Act of 2007 (Provision on using technology for quality); HR 3425, Cancer Screening Coverage Act of 2007 (Mandated cancer screening); HR 3341, Quality Health Care Coalition Act of 2007 (Provision exempting physicians from antitrust laws); S 459/HR 758, Breast Cancer Patient Protection Act of 2007 (Minimum hospital stay for breast cancer); S 40, National Insurance Act of 2007 (Optional federal charter for insurance); S 400/HR 2851, Michelle's Law (Mandatory coverage for students when on medical leave); HR 4460/S 2477, Health Care Choice Act of 2007 (Cross-state selling of insurance); HR 4986, National Defense Authorization Act for Fiscal Year 2008 (Provision that extends Family Medical Leave Act to service members); S 1881/HR 3195, ADA Restoration Act of 2007; HR 6142, (ERISA and disability benefit damages); HR 5840, Insurance Information Act of 2008; S 3406, ADA Amendments Act.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
HR 3361, Pension Protection Technical Corrections Act of 2008; HR 6143, Pension Protection Act ERISA Amendments of 2008
S 1893, Children's Health Insurance Program Reauthorization Act of 2007 (Expansion/extension of SCHIP ); S558/HR 1424, Mental Health Parity Act of 2007 (Secure equal treatment for mental health benefits); HR 1038/S 623, Access to Life-Saving Medicine Act (Biogenerics-approving generic Bio pharmaceuticals); S 316, Preserve Access to Affordable Generics Act (Regulate Generic/Brand patent settlements); S 1501/S 1695, Affordable Biologics for Consumers Act (Generic Bio-pharmaceuticals); S 334, Healthy Americans Act (Universal health coverage replaces employer coverage); S 1899, Universal Health Coverage Act of 2007 (Mandatory health insurance coverage); S 242/HR 380, Pharmaceutical Market Access and Drug Safety Act of 2007 (Drug importation-Canada, et al.); HR 1076/S616, HIPAA Recreational Injury Technical/Correction Act (Mandatory coverage for recretional activity); HR 676, United States National Health Insurance Act (National health insurance); HR 1368, Personalized Health Information Act of 2007 (Financial incentives for personal health records); S 1490, Federal Employees Electronic Personal Health Records Act of 2007 (health information technology); S 1544, Medicare Quality Enhancement Act of 2007 (CMS data release); S 1693, Wired for Health Care Quality Act (Health information technology); HR 1368, Personalized Health Information Act of 2007; HR 5422, TRUST in Health Information Act of 2008; S 1693, Wired for Health Care Quality Act; S 1814, Health Information Privacy and Security Act; HR 6357, ProTecht Act of 2008; HR 6898, Health Information Technology Act of 2008; HR 6582, Small Business Choice Act of 2008; S 2795, SHOP Act; HR 6210, SHOP Act; S 2818, Small Busienss Health Plans Act of 2008.
S1481/HR 2497, Fair and Reliable Medical Justice Act (Medical malpractice reform/health courts); S618, Insurance Competition Act of 2007 (Repeal McCarran-Ferguson); HR 3341, Quality Health Care Coalition Act (Physician antitrust exemption)
HR 3162, Children's Health & Medicare Protection Act of 2007 (Medicare Payment/Reimbursement Reform); S.1218/HR 2034, Medicare for All Act (Medicare "buy-in"); S. 130/HR 1990, Medicare Cost Contract Extension & Retirement Act of 2007 (private sector role in Medicare); S 3/HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 (Government Negotiation of Medicare Drug Prices); S 1102, Part D Equity for Low Income Seniors Act of 2007 (Special benefits for low income seniors); HR 1663, Medicare Mental Health Modernization Act of 2007 (Medicare Mental Health Parity); HR 976, Children's Health Insurance Program Reauthorization Act of 2007 (SHIP Extension and Expansion); HR 2184, Enhanced Health Care Value for All Act of 2007 (Comparative Effectiveness Research Institute; HR 971, Community Pharmacy Fairness Act of 2007 (Medicare Pharmacist Antitrust Exemption), HR 4327, Medicare Chronic Care Practice Network (Establish a Medicare Chronic Care Practice Research Network to develop and evaluate evidence based chronic care management for Medicare beneficiaries); HR 1193, Kidney Care Quality and Education Act of 2007 (Modernize and improve the Medicare ESRD program); HR 6331, Electronic Prescription in Medicare; HR 6331, Medicare Improvements Act of 2008 (dealing with physician reimbursements and Medicare Advantage funding cuts); H. Res. 1368, Medicare "trigger" to warn against funding problem.
HR 914, Tax equity and Affordability Act of 2007; HR 2639, Promoting Health for Future Generations Act of 2007; HS 3234, HSA Improvement and Expansion Act of 2007, S 46, Affordability in the Individual Market Act; S 397, Tax Equity and Affordability Act of 2007; HR 5719, Taxpayer Assistance & Simplification Act (HSAs); HR 3997, Heroes Earnings Assistance and Relief Tax Act of 2007 (FSA); HR 2638, Consolidated Security, Disaster Assistance & Continuing Approp. Act; HR 6049, Energy Improvement & Extension Act (tax extenders, DMT); HR 7005, Alternative Minimum Tax Relief Act of 2008; HR 7060, Renewable Energy & Job Creation Tax Act of 2008 (Tax extenders); HR 6288, Retiree Health Account of 2008.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of